|
Olivier Brandicourt (born 13 February 1956 in Casablanca) is an French business executive and physician, and the current chief executive officer of Sanofi. ==Career== Brandicourt was Chief Executive Officer and Chairman of the Board of Management of Bayer HealthCare AG,〔Bayer HealthCare, (Executive Committee ), February 25, 2015〕 where he was responsible for leading the company’s healthcare portfolio globally, encompassing pharmaceuticals, consumer care, animal health and medical care businesses.〔 In February 2015, he was appointed as the Chief Executive Officer of Sanofi.〔Noemie Bisserbe, (Sanofi Names Olivier Brandicourt CEO ), ''The Wall Street Journal'', February 20, 2015〕〔Andrew Ward, (Five big challenges facing Sanofi’s new chief Olivier Brandicourt ), ''Financial Times'', February 15, 2015〕〔Andrew Ward, (Sanofi appoints Brandicourt as CEO ), ''Financial Times'', February 19, 2015〕 His golden handshake of US$4.5 million upon taking on the appointment was criticized by French Ministers Stéphane Le Foll and Ségolène Royal.〔Ed Silverman, (French Government Slams Sanofi Over Brandicourt Pay Package ), ''The Wall Street Journal'', February 24, 2015〕 Previously Brandicourt served as a member of the Executive Leadership Team of Pfizer Inc. and consecutively led several of the firm’s global business units.〔〔Bloomberg, (Executive Profile ), February 25, 2015〕 He started his career as a physician at the Institute of Infectious and Tropical Diseases of the Pitié-Salpêtrière Hospital in Paris, where he worked primarily on malaria.〔 He practised medicine in the Republic of the Congo for two years.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Olivier Brandicourt」の詳細全文を読む スポンサード リンク
|